We are live on
!
Find out more
SRC
Sage Rhino Capital Portfolio holdings
AUM
$617M
1-Year Est. Return
28.74%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+28.74%
3 Year Est. Return
+86.8%
5 Year Est. Return
+76.14%
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$51.2M
(+20%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
13.4%
Top 10 Holdings %
Top 10 Hldgs %
44.27%
Holding
193
New
15
Increased
115
Reduced
31
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VINC
Vincerx Pharma, Inc. Common Stock
VINC
|
+$32.6M |
| 2 |
iShares Gold Trust
IAU
|
+$2.59M |
| 3 |
Palantir
PLTR
|
+$1.46M |
| 4 |
Morgan Stanley
MS
|
+$1.33M |
| 5 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$3.68M |
| 2 |
EV
Eaton Vance Corp.
EV
|
+$1.89M |
| 3 |
GUT
Gabelli Utility Trust
GUT
|
+$1.3M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$1.26M |
| 5 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$888K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.85% |
| 2 | Healthcare | 13.21% |
| 3 | Financials | 3.74% |
| 4 | Consumer Discretionary | 3.39% |
| 5 | Communication Services | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $344K | 0.11% |
+867
| New | +$334K |
|
127
Mastercard
MA
$493B
| $336K | 0.11% |
943
+7
| +0.7% | +$2.44K |
|
128
Abbott
ABT
$187B
| $335K | 0.11% |
2,794
-92
| -3% | -$10.9K |
|
129
Chevron
CVX
$366B
| $328K | 0.11% |
3,130
+20
| +0.6% | +$1.95K |
|
130
SPDR Gold Trust
GLD
$142B
| $325K | 0.11% |
2,029
+601
| +42% | +$101K |
|
131
Sanofi
SNY
$104B
| $325K | 0.11% |
6,571
+61
| +0.9% | +$2.93K |
|
132
Vertex Pharmaceuticals
VRTX
$126B
| $325K | 0.11% |
1,513
+265
| +21% | +$58.2K |
|
133
Illumina
ILMN
$28.4B
| $321K | 0.11% |
860
-97
| -10% | -$39.6K |
|
|
NVO
134
Novo Nordisk
NVO
$209B
| $314K | 0.1% |
9,322
+444
| +5% | +$15.8K |
|
135
Autodesk
ADSK
$52.6B
| $313K | 0.1% |
1,130
| – | – |
|
136
ExxonMobil
XOM
$634B
| $308K | 0.1% |
+5,509
| New | +$289K |
|
137
SAP
SAP
$238B
| $300K | 0.1% |
2,447
+187
| +8% | +$23.7K |
|
138
Starbucks
SBUX
$120B
| $300K | 0.1% |
2,746
+24
| +0.9% | +$2.52K |
|
139
AbbVie
ABBV
$435B
| $284K | 0.09% |
2,626
+40
| +2% | +$4.28K |
|
140
Bloom Energy
BE
$64.6B
| $280K | 0.09% |
10,342
| – | – |
|
141
DaVita
DVA
$11.7B
| $280K | 0.09% |
2,597
| – | – |
|
142
iShares MSCI Emerging Markets ETF
EEM
$30B
| $275K | 0.09% |
5,150
| – | – |
|
143
Pfizer
PFE
$153B
| $274K | 0.09% |
7,556
-11
| -0.1% | -$391 |
|
144
Booking.com
BKNG
$161B
| $273K | 0.09% |
2,925
-25
| -0.8% | -$2.22K |
|
145
Walmart Inc
WMT
$890B
| $273K | 0.09% |
6,024
-264
| -4% | -$12.2K |
|
146
Vanguard Real Estate ETF
VNQ
$39.1B
| $270K | 0.09% |
2,941
| – | – |
|
147
Diageo
DEO
$53.6B
| $262K | 0.09% |
1,597
+50
| +3% | +$8.18K |
|
|
WBK
148
DELISTED
Westpac Banking Corporation
WBK
| $258K | 0.08% |
13,896
+348
| +3% | +$6.14K |
|
149
Cleveland-Cliffs
CLF
$6.99B
| $256K | 0.08% |
12,710
-3,424
| -21% | -$55.7K |
|
150
McDonald's
MCD
$195B
| $251K | 0.08% |
1,119
+105
| +10% | +$22.5K |
|
Similar funds
VHMC
ACP
MC
TAM
AMG
KFAS
DTL
RC
Sage Rhino Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Sage Rhino Capital held 193 positions worth $304M, up 20% from $253M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Sage Rhino Capital deployed $40.8M of net new capital in Q1 2021, opening 15 new positions and adding to 115 existing holdings. Its largest new stake was Vincerx Pharma, Inc. Common Stock: 80,910 shares worth $31.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was DocuSign, an estimated $3.68M trimmed.
- Sage Rhino Capital's largest Q1 2021 buy was Vincerx Pharma, Inc. Common Stock: 80,910 shares worth $31.2M.
- Sage Rhino Capital added most to iShares Gold Trust in Q1 2021, an estimated $2.59M increase.
- Sage Rhino Capital's biggest Q1 2021 reduction was DocuSign, cutting an estimated $3.68M.
- Sage Rhino Capital fully exited Eaton Vance Corp. in Q1 2021, selling an estimated $1.89M.
- Sage Rhino Capital's ten largest holdings make up 44% of its $304M portfolio in Q1 2021.
- Sage Rhino Capital opened 15 new positions and closed 8 in Q1 2021.
- Sage Rhino Capital's portfolio value rose 20% quarter-over-quarter to $304M.
Based on Sage Rhino Capital's 13F filing for Q1 2021, filed 4 May 2021.